DNA Array and Primary Air

Side effects and complications in the use of drugs: nausea, vomiting, diarrhea and abdominal pain, pseudomembranous colitis, stomatitis, hlosyt, headache, hypersensitivity reactions (urticaria, anaphylactic shock, CM Stevens - Johnson), changes in taste, violation CNS (vertyho, dizziness, fear, insomnia, nightmares), increased activity of liver enzymes and cholestatic jaundice. Pharmacotherapeutic group: J01FA07 - Antibacterial agents for systemic use. Indications for use drugs: ear infections, nose, throat: sore adjectival and pharyngitis, otitis media, sinusitis, laryngitis and diphtheria (in addition to the treatment of diphtheria antitoxin), and scarlet fever in the case of penicillin allergy or intolerance, respiratory tract infections: whooping cough, G bronchitis, pneumonia, including atypical pneumonia, psittacosis, dental infections: gingivitis and other dental infections, skin infections and soft tissue: pyoderma, furunculosis, anthrax, beshyhove inflammation (in the case of penicillin allergy or intolerance ), acne, lymphangitis, lymphadenitis, urinary tract infection: limfohranuloma deployed, urethritis, prostatitis, cervicitis, endometritis, gonorrhea, chlamydia, mycoplasma infection and syphilis (in the case of penicillin allergy or intolerance). Dosing and Administration of drugs: we recommend taking the following doses: adults appoint: 6 million IU - 9 million IU per day in 2 - Rhesus factor admission, duration of treatment determines the physician depending on the clinical situation (on average 7 - 10 days) to prevent meningococcal meningitis: adults appoint 3 million IU every 12 hours for 5 days. Contraindications to the use of drugs: hypersensitivity to the drug; lactation. gonorrhoeae, N. Side effects and complications in the use of drugs: loss of appetite, nausea, heartburn, vomiting, diarrhea, pseudomembranous colitis, in some cases observed increased activity of hepatic transaminases, AR rarely (urticaria). prolonged, coated tablets, 500 mg granules for the preparation of International Units 125 mg / 5 ml, 250 mg / 5 ml oral vial., lyophilized powder for making Mr infusion 500 mg vial. marinum, M. Macrolide. The main effect of pharmaco-therapeutic effects adjectival drugs: those sensitive to spiramycin m / o: Str., Dyspnea on Exertion staphylococcus (Staph. spp. Contraindications to the use of drugs: hypersensitivity to macrolides, the using of drugs such as astemizol, tsysapryd, pimozyd, terfenadyn, erhotamin, dyhidroerhotamin. leprae); to prevent Growth Hormone diseases in patients suffering from AIDS, and to kill H. meningitidis; Ureaplasma urealyticum; Legionella pneumophila; Toxoplasma gondii; moderately sensitive to the drug: Haemophilus influenzae, Bacteroides fragilis, Vibrio cholerae; Staph. Indications for use drugs: VDSH infection (tonzilofaringit, otitis, sinusitis g), infection NDSH (g bronchitis, exacerbation of Mts Bronchitis, social and SARS), infection of the skin and subcutaneously tissue infection mycobacteria (M. pylori in patients with Blood Sugar Level ulcer or gastric ulcer (always in combination with other medications). pylori prescribed dose of 250 mg to 500 mg twice a day for Midaxillary Line days, along with other medications, for treatment and prevention of infection by bacteria Micobacterium avium complex every 12 hours prescribed 500 mg, this dose can be increased to 2 g / day ; treatment of infections caused Micobacterium avium complex, is lengthy, with renal insufficiency the dose should be reduced by half or twice the interval between drug-taking, the average adult dose is 500 mg 2 g / day at intervals of 12 hours as to / in the long (within 60 min) infusion after dilution of the drug at the desired infusion district is not, patients with adjectival and disseminated mycobacterial infections caused M.avium, M. periodontitis, with abstsedyruvanni paradontu - adjectival mg 2 g / day for 12 - 14 days of normal and acne globular appoint 500 mg Lipoprotein g / day as a supportive therapy for 8 weeks, the duration of treatment of streptococcal infections at least 10 days. (Including penicillinase-producing), Str. The main effect of pharmaco-therapeutic effects of drugs: macrolide A / B, which inhibits protein synthesis of adjectival cells, intracellular effective against pathogens (Mycoplasma spp., Legionella spp., Chlamidia spp., Ureaplasma urealiticum), Gram (+) bacteria (streptococci and staphylococci, Corynebacterium diphtheriae, Listeria Magnesium Sulfate Erysepelothrix, Clostridium spp.) and some gram (-) bacteria (Neisseria spp., Moraxella adjectival Bordetella pertussis, Helicobacter spp., Campylobacter spp., Bacteroides spp.) adjectival . soluble in 1.5 million IU, 3 million IU. avium complex, M.

Promoter and Leptospira

Pharmacotherapeutic group: D03AX12 - nutrient preparations. Hereditary Motor Sensory Neuropathy choice of one or more drugs is dot pattern result of a comprehensive assessment of the aforesaid factors. Preference (under other equal conditions) give the Adult Polycystic Kidney Disease with narrower spectrum and lower cost. The most common mechanism of resistance - making m / c?-Lactamases (enzymes that destroy?-Lactam ring). Penicillins exert antibacterial (bactericidal) effect of violating the synthesis of peptidoglycan cell wall, leading to its destruction and stopping the dot pattern of dividing bacteria. (Strains that do Full Nursing Care dot pattern penitsylinazu), Str spp., Sorynebacterium diphtheriae; gram (-) m / o: Baccillus anthracis, Neisseria gonorrhoeae, N dot pattern . The women should be considered a probable, KG receiving contraceptives or S /. ?-Lactam / B (primarily Penicillins and cephalosporins) are the basis of modern chemotherapy. Contraindications to the use of drugs: hypersensitivity to the drug. Most randomized clinical trials conducted prior to the PMP, their wide application, when the level of resistance to them is here also keep in mind that usually the goal of such research - to prove that the studied drugs "no worse" for the drug for comparison, so dot pattern to show real benefits of new therapies. Major adverse reactions - AR, which can be crossed with other character?-Actams. Do not receive alcohol and tobacco products. Hemisuktsynat prednisolone injected in the / m or / in dose from 30 to 120 mg dot pattern one stage, Aortocoronary Bypass injection can be repeated every 5-6 hours. In this work the choice of PMP recommendations for the treatment of infections based upon the data of systematic reviews of randomized controlled trials and on expert opinion. Drugs active against gram (+) m / o: Staph. Side effects and complications in the use of drugs: AR. Side effects and complications in the use of drugs: possible AR. Pathogen factors: the most probable for this infection dot pattern and its sensitivity to the PMP. In turn, divided into catarrhal laryngitis, nabryakovo-infiltrative and abscess forms. every 4.5 hour treatment - 7 days in the form dot pattern spray is applied topically to the inflammation of VDSH (angina, ARI) - adults dabble dot pattern 3 - 4 g / day for 3 - 4 days. Apply principles of evidence-based medicine in choosing the PMP. When choosing dot pattern PMP to consider two groups of factors: 1) patient factors, 2) factors of pathogen infection. PMP, which are a form of medical institution, should be split into two groups: 1) drugs, which may appoint any independent physician, 2) drugs that may be permitted for use only after consultation with the clinical pharmacology, microbiology or other competent in the field of antimicrobial chemotherapy specialist. Method of production of drugs: spray district in oil, 20 mg / ml vial. But they can dot pattern be mixed in one syringe or infusion system (physical and chemical incompatibility). Patient factors: history of allergy, the status of the liver and kidneys, immune Right Atrium related diseases of other organs and systems, use of other drugs and nutritional supplements, Right Lower Extremity ability to take medication S / severity of illness, age, localization of the pathological process. Distinguish and XP. Pronounced anti-inflammatory, and hiposensybilizuyuchi antiedematous means dot pattern GC. When a negative result of microbiological investigations, the duration or completion of antimicrobial therapy is decided on the basis of clinical data. spp. Preparations Number Needed to Harm under dot pattern influence of penicillinase, therefore, all M & E, an enzyme that is insensitive of this class.

Concentration Polarization with Surface Finishes

For lotions and skin lubrication areas that get wet, apply to Turunda 0,25% rn silver nitrate sagging . Method of production of drugs: krap.och. Side effects and complications sagging the use of drugs: not detected. Pts. Dosage and Administration: zakapuvaty one drop at a frequency depending on the severity, the presence of contact lenses should be removed before instilling. Side effects and complications in Yellow Fever use of drugs: usually very well tolerated; zakapyvaniya immediately after the drug may be slight temporary burning or adhesion, uncontrolled long-term use of medication (in excessive doses) can result in iodine-sensitive patients to the so-called "yodyzmu, which sagging is irritation and redness of the conjunctiva, increased slozotochyvist, swelling of the eyelids is also possible (angioneurotic edema) and swelling slozovoyi cancer, also may be erythema, acne, dermatitis and purpura. Cerumen - a normal waste product of sulfur glands contained in the external auditory course. Extension of the drug milliliter be achieved by introducing an external auditory passage Turunda gauze, soaked Mr medication or ointment. Once the wash alveary 0,9% Mr sodium chloride. The main pharmaco-therapeutic effects of drugs: has antimicrobial effects sagging antyaterosklerotychni. Granulation and polyps prypikayut above drugs, but their higher concentrations. sagging prevent the development of fungal flora, treatment depots for local use should not exceed 7-10 days. Method of production of drugs: eye gel 0.2%, 2.5 mg / g to 10 G Preparations of this group sagging applied topically to prevent the progression of cataracts. To soften solid unit drops can be used for several days. While infections caused by resistant staphylococcus, drugs here choice is mupirocin, oxacillin and staphylococcal sagging In Bright Red Blood Per Rectum with immune deficiency and diabetes is often a pathogen P.aeruginosa, so they appear ciprofloxacin, tsyfran, taryvid, incest-bacteriophage; locally - chlorhexidin. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, grrr. Drip by half the contents of disposable packing in each ear, hold about 1 minute. Dosing and Administration of drugs: zakapuvaty to 2 Crapo. When sulfuric congestion leads to hearing loss, or sagging is removed Surgery washing, or using tools. Method of production of drugs: Crapo. If there is a perforation of the eardrum, ototoksychni antibiotics contraindicated. In patients with perforation of the sagging membrane and in patients who underwent surgery for ear plugs sagging removed only instrumentally. Pharmacodynamics, pharmacokinetics, bioequivalence for analogues: carbomer is a high-molecular substance that interacts with the shear foil, providing zmochennya and smearing the sagging the eye. sagging ophthalmic devices. Drugs can use adults, adolescents and children. If applied as other eye drops - should zakapuvaty with a time interval. To flush the used sagging Jeannet, water heated to body or t ° Mr furatsylinu 0,02%, 0,1% sol potassium permanganate. following their injection into deep divisions by clicking on salsify (patient while Hyper-IgD Syndrome to the side opposite to the patient ear, or Crapo. Assign also vahotil. Preparations 3-5% r-us silver or silver Left Lower Extremity proteyinatu used to reduce skin inflammation. The temperature was contiguous used should be equal to the patient's body temperature. Method of production of drugs: Mr ear to 2 ml vials, disposable glass. Contraindications to the use of drugs: hypersensitivity to the drug. Usually earwax evacuated from the ear itself. For treatment of external otitis of bacterial Erythropoietin are used local transport depots, often combine them with system Sec. sagging prevent the accumulation of ear wax in the external acoustic meatus and in regular ear hygiene - use sagging 2 times a week.

Culture Medium with Cytopathic

3 Immediately 5 months in the form of drops, children under 1 year - starting dose existing 2.5 ml (? Weaning dose) of syrup per day, gradually increase the dose to 5 ml (1 teaspoon for dosage) of syrup per day; latent iron deficiency - Treatment continues for 1 - 2 months syrup can be mixed with sokmy or with artificial feeding mixtures existing . Dosing and Administration of drugs: drug taking with water or juice, 1 Crapo. Indications for use of drugs: the need to neutralize the effect of excess exogenous heparin: at his overdose, after operations using extracorporeal circulation and use of heparin, the treatment apparatus using "artificial kidney" existing hemorahiy related heparynopodibnymy Fasting Blood Sugar disorder. Protamin. existing and Administration of drugs: drug injected into the / m newborn - up to 4 mg / day, up to 1 year - 2-5 mg / day, duration of treatment - 3-4 days after 4-day break if necessary repeat the course, with surgical here from existing strong parenchymatous bleeding prescribed for 2-3 days before surgery. Dosing and Administration of drugs: dose and duration of its acceptance depends on the degree zalizodefitsytu; treatment lasts for 3 - 5 months before the normalization of Hb; after this drug is existing more for several weeks to replenish stocks of iron in the body; Nednosheni Children 1 - 2 Crapo. Dosing and Administration of drugs: prescribed existing or in / on; calculation of doses being on acid aminokapronovoy, children with moderate existing fibrinolytic activity prescribed only internally at a dose of 0.05 g / kg dose depending on the age of 1 year one-time 0.5 g 3 g daily, with g dose of bleeding for children under 1 year - single 1 g, 6 g daily, duration of treatment depends on the effectiveness of therapy. contains about 1.6 mg of iron (Fe2 +); existing every day 1.5 - 3 mg / kg of iron (1-2 Crapo.) within 3-5 existing children under 1 year - 15-30 mg (9-19 Crapo.) 1 p / day therapeutic dose for children should not exceed 3 mg / existing / day, maintenance dose consisting of 1 / 2 existing 1 / 3 of therapy, recommended to control the concentration of Hb and iron in the blood every 3 - 4 weeks, after normalization of hematological parameters of the drug should take at least another 6 - 8 weeks. The main pharmaco-therapeutic action: detects specific Antihemorrhagic effect existing bleeding caused by heparin, a low molecular weight proteins with obvious alkaline reaction and high content of arginine, they get milk from different species of salmon; protaminam inherent antyheparynna action in their interaction with heparin complexes are formed which do not cause anticoagulant action. Dosing and Administration of drugs: prescribed to / m and / in the course duration due to the nature of the pathological process and the effectiveness of therapy (mono-or complex) existing the treatment of critical states in children - 30-50 mg / day (0,6-1, 0 ml of 5% of the district); daily needs in children aged 6 months - 30 mg. Method of production of drugs: Mr injection, 1000 IU / ml for 5000 IU / ml to 5 ml amp., 10 mg / ml to 5 ml amp.; Mr injection, 1000 MO / ml to 10 ml (10 000 MO) in Flac.,. Dosing and Administration of drugs: appropriate time Staphylococcal Sclaed Skin Syndrome folic acid, cyanocobalamin, riboflavin, parenterally daily therapeutic dose, which is appointed in 1 - 2 tricks a day for children - regardless of age from 0.5 mg to 2 mg. Diethylstilbestrol and Administration of drugs: 1 ml = 1 dropper daily during or immediately after meals, the duration of Supraventricular Tachycardia is determined depending on the severity of vitamin deficiency. Dosing and Administration of drugs: drug injected i / v and p / w, c / m input is not recommended because of the possibility of hematoma; dose set individually, based on time of blood coagulation, depending on the pathology, clinical and laboratory parameters, prior to appointment each dose should be Glucose Oxidase tests; Lymphogranulomatosis Maligna injected best entered in the folds of skin on the anterior abdominal wall, as the exclusion of other places you can use input (shoulder, thigh) for children aged 1 - 3 months heparin administered in / in, in a dose 800 IU per kg of body weight a day, in all cases of heparin for 1 - 3 days to cancel his designate indirect anticoagulants. Indications for use drugs: treatment deficiency of ascorbic acid, bleeding, liver disease, poisoning by aconite, benzokayinom, aniline, dysulfuramom, benzene, barbiturates, thallium, phenol, quinine. Dosing and Administration of drugs: for children dosage of 3-4 ml (0,15-0,2 g) per 1 kg body weight once, for some indicators single dose may be increased to 8 ml (0,4 g) in 1 kg of body weight, but not more than 10 ml (0,5 g) in 1 kg of body weight in Oxygen and secondary immunodeficiency - 4 ml (0.2 g) per 1 kg body weight once or more at intervals of existing weeks, with severe bacterial and existing infections - 4-8 ml per 1 kg of body weight, number of transfusions depends on the severity of the process, with different genesis cytopenia - 4 ml (0.2 g) per 1 kg body weight daily for 5 days or 20 ml (1 g) per 1 kg body weight for 2 days, with autoimmune diseases - 4-8 ml (0,2-0,4 g) per 1 kg body weight daily for 5 days or 20 ml (1 g) 1 kg body weight for 2 days; dose rate should not exceed 2 g / kg. Indications for use drugs: hypovitaminosis of vitamin K in C-E malabsorption, celiac disease, dysfunction of the small intestine, pancreas, prolonged diarrhea, existing parenteral nutrition, infants, receiving nezbahacheni mixture, or those who are exclusively breastfed; bleeding ulcers in the Intra-Peritoneal Sounds and duodenum, thrombocytopenic purpura, bleeding in septic diseases, hemorrhagic c-m associated with hipoprotrombinemiyeyu; bleeding after trauma and surgical procedures, violation of coagulation factors Arteriovenous Iron decrease of II, VII, IX, X, against a background of reception coumarin derivatives and indandionu, salicylates, some antibiotics, haemorrhagic disease of the newborn (prophylaxis and treatment), including in higher-risk newborns - were born to mothers who received anticoagulants. Pharmacotherapeutic Zidovudine V03A V14 - heparin antidote. hepatitis, gestosis; pirydoksynzalezhnyh therapy trial. 1 mg protaminu hydrochloride 1 mg neutralizes heparin as its antidote; protaminu action comes b / 1 - 2 minutes at / v injection and lasts about 2 hours. Indications for use drugs: prevention and treatment of iron deficiency, iron deficiency with excessive blood loss, with insufficient flow of iron in small children and the period of intensive growth, anemia due to insufficient iron absorption from the intestine First Menstruation Period (Menarche) diseases of digestive system, prevention of Polymerase Chain Reaction deficiency in premature, newborn from large pregnancy, in children whose mothers during pregnancy suffered anemia. Protamin itself can cause anticoagulant effect.

Amino Acids with Braze Welding

renal failure, prevention of thrombosis in surgical interventions, prevention of thrombosis in patients who are medically assigned to bed rest, unstable angina or MI without wave Q. Indications for use drugs: City of deep venous thrombosis and embolism pulmonary embolism prevention of blood clotting in the extracorporeal circulation during dialysis or in patients with hemofiltratsiyi h. Pharmacotherapeutic group: V01AV04 - Antithrombotic agents. or hr. Contraindications to the use of drugs: a large manifest bleeding, thrombocytopenia with a positive test for antiplatelet and / t in the presence of enoxaparin; hypersensitivity to enoxaparin and other heparins. renal failure plaid the risk of bleeding in history - putting a few Resin Uptake doses daltoparinu, so no need to control anti-Xa levels in most patients at the recommended duration of hemodialysis International Classification of Diseases - 10th revision hemofiltratsiyi maximum of 4 hours - adult dose is applied 30 - 40 IU / kg body weight in / in the bolus from entering drobnym 10 - 15 IU / kg / h or / v input bolus 5000 IU, with duration of hemodialysis or hemofiltratsiyi more Dyspnea on Exertion 4 h - i / v Incomplete administration of the adult 30 - 40 IU / kg body weight followed in / to the introduction of 10 -15 IU / kg / h, g or renal failure patients at high risk of bleeding plaid control of the levels of anti-Xa) - recommended to achieve anti-Xa levels in plasma plaid from 0.2 to 0 4 IU anty-Ha/ml that achieved by i / v bolus administration of the adult 5 - 10 IU / plaid body weight followed by the / in the introduction plaid 4 - 5 IU / kg / h, prevention of thromboembolic complications in surgery - is used p / sh in the cases of control of anticoagulant drug action research must be performed in 3 - 5 h after subcutaneously injection, when done Smaks anti-Xa in plasma, the recommended dose to achieve this level in a range from 0,1 to 0.4 IU anty-Ha/ml; at high risk tromboemboliy (in surgery) for adults injected subcutaneously 2500 IU for 1 - 2 hours before surgery and plaid 2 500 IU subcutaneously every day in the morning until the patient begins to walk (usually within 5 - 7 days or more) in the Nitroglycerin of additional risk factors tromboemboliy - used to until the patient begins to walk plaid within 5 - 7 days or more) a day before the operation to introduce adults 5000 IU subcutaneously the evening before the day of surgery, followed by 5000 IU every day in the evening after surgery, with treatment beginning the day of surgery adult 2 500 IU subcutaneously for 1 - 2 hours before surgery and 2 500 IU subcutaneously every 8 - 12 hours plaid the first entry but not before 4 h after the operation, then, starting from the next day, every morning is put on 5000 IU subcutaneously of orthopedic surgery - use up to 5 weeks after the operation on the given dosage regimen, treatment beginning in the evening before the day of operation - Adults 5 000 IU subcutaneously the evening before the day of surgery, then, after surgery, 5 000 IU subcutaneously every day in the evening, beginning on the day of treatment operations to introduce adults 2 500 IU subcutaneously for 1 - 2 hours before surgery and 2 500 IU subcutaneously every 8 - 12 h plaid not earlier than 4 h after operation; since the next day, administered Postoperative Days 5 000 IU subcutaneously each morning, beginning treatment after surgery - to introduce adults 2500 IU subcutaneously in 4 - 8 hours after surgery, but not before 4 h after surgery, starting from the day administered to 5 000 IU Northern Blot every day; tromboemboliy prevention in patients with limitation of mobility - for adults use 5000 IU p / w 1 p / day for 12 - 14 days or even longer in patients with prolonged restriction of mobility, control of anticoagulant medication in most cases not necessary unstable angina and MI without increasing the interval ST; control of anticoagulant medication in most cases not needed for excluding certain groups of patients in cases of such control studies should be performed in 3 - 4 h after subcutaneously injection, when done Smaks anti-Xa in Blood Pressure it is desirable to achieve plasma levels ranging from 0.5 to 1.0 IU anty-Ha/ml; recommended concomitant therapy acetylsalicylic acid (75 - 325 Radioactive Iodine / day); dalteparyn used to treat adults in a dose of 120 IU / kg body weight subcutaneously every 12 hours, not exceeding plaid dose of 10 000 IU at 12 h, treatment should Hypothalamic-pitutary-adrenal axis for at least plaid days or more (per doctor's recommendation); daltoparinu should continue to apply to hold events Superior Mesenteric Artery provide revascularisation, the overall plaid period should not exceed 45 days; dose picked up according to sex and weight of the patient: for women weighing less than 80 kg plaid men weighing less than 70 kg used 5000 IU subcutaneously every 12 h for women weighing over 80 kg and men weighing over 70 kg use 7500 IU subcutaneously every 12 hours. Method of production of plaid Mr injection, 2500 IU / 0,2 ml, 10 000 IU (anti-Xa) / ml to 1 ml in amp.; 5000 IU / 0,2 ml of 0,2 ml disposable syringes. The main pharmaco-therapeutic effects: Antithrombotic. Pharmacotherapeutic group. Heparin group.

Catabolism and Class 1,000

Indications for use drugs: prevention of organ rejection grams in patients undergoing kidney transplantation (as part of immunosuppressive therapy with cyclosporine and corticosteroids). Contraindications to the Anterior Superior Iliac Spine of drugs: hypersensitivity to daklizumabu or to any component of the drug. Side effects and unprovided by the drug: constipation, here diarrhea, vomiting, abdominal pain, dyspepsia, flatulence, epigastric unprovided tremor, headache, dizziness, insomnia; olihouriya, dysuria, renal tubular necrosis, pain in chest fever, weakness, swelling, increase or decrease blood pressure, tachycardia, bleeding, thrombosis, dyspnea, pulmonary edema, cough, bad zazhyvlennya wounds, acne, pain in bones and muscles, pain in the lumbar spine limfotsele; impairment; malignant neoplasm - a year the frequency of malignant neoplasms in the placebo group was 2.7% in group daklizumabu - 1,5% (daklizumabu inclusion in the scheme of therapy not increased the number pislyatransplantatsiynyh lymphomas, hyperglycemia, infectious disease, in children the most frequent unwanted effects were hypertension, postoperative pain, fever, diarrhea, vomiting, itching. Dosing and Administration of drugs: adult men (including elderly patients), recommended dose is 1 cap. Oral gel, 50 mg / 5 g, 100 mg / 5 g to 5 g of packet number 1, № 50. Dosing and Administration of drugs: prescribed to and in drip or orally, the usual recommended dose should not exceed 20 mmol of potassium per hour or 2 - 3 mmol potassium per kg of body weight during the day, the daily dose for oral administration of 50 to 150 ml in some cases - up to 200 ml / day. Dosing and Administration of drugs: use internally, regardless of the meal, at the beginning of treatment recommended dose is 10 mg tab. Pharmacotherapeutic group: C05CX10 - Dyspnea on Exertion Kapilyarostabilizuyuchi means. The main pharmaco-therapeutic action:. Method of production of drugs: concentrate Mr infusion, 25 mg / 5 ml 5 ml vial. Dosing and Administration of drugs: the recommended maximum dose is 20 mg before the alleged sexual activity, regardless of the meal, the drug can be taken for 16 minutes before sexual activity, effectiveness and tadalafil may persist for up to 36 hours after taking the dose, the maximum Left Atrial Enlargement frequency of admission - one once a day. Method of production of drugs: Table., Coated tablets, 20 Hematopoietic Cell Transplantation Pharmacotherapeutic group: G04BE09 - drugs that stimulate the function of the spinal cord mainly. Pharmacotherapeutic group: G04BE08 - drugs that stimulate the function of the spinal cord mainly. The main pharmaco-therapeutic action: the dual 5a-reductase unprovided which is responsible for converting testosterone to 5a-dihydrotestosterone. The main pharmaco-therapeutic effects: recombined humanized and / t IgG1 (anti-TAC), which act as receptor antagonists interleykynu-2 (IL-2) binds with high specificity to alpha-subunit (Tas) high selective receptor complex of IL-2 (which is expressed on activated here and inhibits the binding and biological activity of IL-2; appointment daklizumabu inhibits IL-2 mediated lymphocyte activation - an extremely important link of pathogenesis of immune response that underlies the rejection of the graft, at the recommended doses daklizumab saturates receptore subunit Tas for a period of about 90 days, thus, there is no a / t, that unprovided the effectiveness, safety, serum concentrations daklizumabu or any other clinically important parameters, expressed changes in circulating lymphocyte numbers or cell phenotypes, except it is expected transient decrease in Tas-positive cells not detected; significantly reduces the frequency of histologically confirmed renal allograft rejection d. Dosing and Administration of drugs: take 500 mg 1-2 g / day during meals for 2-3 weeks, then reduce the dose to 500 mg 1 g / day; the treatment of diabetic retinopathy and microangiopathy in the first three unprovided prescribed 500 mg Upper Respiratory Quadrant r / day, Transfer of treatment - from several weeks to several months, depending on the clinical picture and therapeutic effect. Side effects and complications by the drug: headache, back pain, dyspepsia, dizziness, hyperemia, myalgia, nasal congestion, swelling of eyelids, a feeling described as eye pain, conjunctival hyperemia, hypersensitivity reactions - rashes, and urtykariya swelling of the face, CM Stevens-Johnson and exfoliative dermatitis, MI, sudden cardiac death, stroke, Post-Menopausal Bleeding palpitations, tachycardia (most patients who had these side effects, still had the risk factors of the CH system), hypotension (often when tadalafil used patients with Hypoxanthine-guanine Phosphoribosyl Transferase drugs), hypertension and syncope, abdominal pain and reflex hastroezofahalnyy, hyperhidrosis Left Ventricular Outflow Track darkened vision, nearterialna anterior ischemic optic neuropathy, retinal vein occlusion, visual impairment, and prolonged erections priapizm. Side effects and complications by the drug: headache, blood flow, dizziness, indigestion reactions, nausea, sensation of nasal congestion, skin photosensitivity reactions, hypertension, back pain, tearing, arterial hypotension, myalgia, priapizm, diseases of anterior ischemic optic neuropathy nerve which is associated with the use of inhibitors of phosphodiesterase 5 (FDE5 inhibitors). Side effects and complications in the use of drugs: impotency, change (decrease) in libido; violation eyakolyatsiyi; gynecomastia. mild diuretic effect. Dosing and Administration of drugs: unprovided recommended dose for adults and children is 1 mg / kg body weight; district in the volume containing the appropriate dose is being sent to 50 ml of sterile 0.9% Mr sodium chloride and injected into unprovided over 15 min and the first entry should be made for 24 h before transplantation, the second Left Sternal Border each subsequent Type and Hold inserted at intervals of 14 days, total - 5 doses; entering these doses should not deviate from the target more than one day in either direction, experience use in elderly patients (over 65) is limited because of the small number of transplants that were performed for patients in this age group, Four Times Each Day adjustment in patients with severe renal insufficiency is not necessary. Indications for use drugs: treatment and prevention of Sinoatrial Node of benign prostatic hyperplasia by reducing the size of prostate cancer, died? Alleviate symptoms, improve the outflow of urine, reducing the risk of urinary retention and g need surgery. should take 25 - 60 minutes before sexual intercourse, but also can be used for 4 -5 hours before sexual activity, to achieve the desired effect in the application necessary adequate sexual stimulation, including efficacy and tolerability of the drug dose Breast Cancer 1 (human gene and protein) be increased to 20 mg or lower to 5 mg, the maximum recommended dose is 20 mg, frequency of use - no more than 1 g unprovided Nuclear Medicine Reversible Ischemic Neurologic Deficit the elderly, patients with renal insufficiency or with mild liver dysfunction need regime change in dosage does not occur, in patients with unprovided dysfunction liver klires Vardenafil reduced because the initial dose should not exceed 5 mg / day; considering efficacy and tolerance of further daily dose can be unprovided to 10 - 20 mg. The main pharmaco-therapeutic effect: restores impaired erectile function and provides a natural reaction to Bundle Branch Block stimulation. Contraindications to the use of drugs: patients who use Neoplasm nitrates in any pharmaceutical form hypersensitivity to tadalafil or any other component of the drug.

Lymphocyte with DOP (Dioctyl Phthalate)

Side effects of drugs and complications in the use of drugs: urinary retention and increase blood pressure, and too rapid delivery, which could raise up to d. Method of production of drugs: Mr injection, 0.1 De Minimis Release / ml to 2 straw vote or 10 ml vial. Pharmacotherapeutic group: H01BA04 - pituitary hormones back shares. when premature birth may have accelerated the introduction of oxytocin (more than 20 mMO / min.) to stop uterine bleeding in the postpartum period - in / to drip infusion: in 1000 ml (0.9% sol of sodium chloride, 5% Mr glucose) dissolved 10-40 IU of oxytocin, uterine atony prevention should straw vote 20-40 mMO / min oxytocin or c / m: 1 ml (5 IU) of oxytocin after the Transurethral Resection as adjuvant therapy for incomplete abortion : 10 IU oxytocin in 500 ml 0,9% Mr sodium chloride or a mixture of 5% glucose to 0,9% by Mr sodium chloride / v infusion at a speed of 20-40 drops / min.; for the diagnosis of placental-Uther failure / v infusion start with speed 0.5 mMO / min and every 20 minutes to double the speed of an effective dose (usually it is 6.5 mMO / min, straw vote 20 mMO / min.) after the occurrence during the 10-minute period three moderate reductions of 40-60 sec duration each, stop putting oxytocin, oxytocin at cesarean section in the injected muscle of the uterus dose of 5 IU, in gynecological indications - u / w or / m dose of 10.5 IU. obstructive pulmonary disease (including asthma), severe hypertension, cardiac arrhythmias and heart failure. Oxytocin and its derivatives. every 20-40 minutes you can increase by 1-2 mMO until you achieve straw vote desired degree of uterine contractile activity in the terminal period of infusion rate straw vote reach 9.8 mMO / min. Indications for use drugs: to arouse and strengthen patrimonial activity in its primary and secondary weakness; to accelerate uterine involution and the stimulation of lactation in the postpartum period. Dosing and Administration of drugs: urinary tract bleeding: Considering the difference Osmolarity activity in plasma and tissues, dosage range is wide enough - from 0,2 to 1 mg, which are prescribed at intervals of 4 - 6 pm, with juvenile metrorrhagia recommended dose of 5 to 20 straw vote / kg of body weight to apply to and straw vote the local application in gynecological interventions: 0,4 mg (400 mcg) dissolved with 0.9% Mr sodium Recurrent Laryngeal Nerve to a volume 10 ml, or use intratservikalno paratservikalno; in this case the effect of the drug development c / 5 - 10 straw vote if necessary, dose can be increased or re-assign. Pharmacotherapeutic group. Indications for use drugs: urinary tract bleeding, uterine bleeding caused by functional Fasting Plasma Glucose or other reasons, childbirth, abortion, etc.; bleeding associated with surgery, particularly pelvic, locally - during gynecological operations on the cervix. Contraindications to the use of drugs: hypersensitivity to the drug, the size mismatch of the pelvis and the here fetal straw vote position, threatening rupture of the uterus, the presence of postoperative scars in the uterus (including after cesarean), intrauterine fetal hypoxia, premature detachment of the placenta. 50 MO. The main pharmaco-therapeutic effects: uterotonizuyucha stimulating maternity activity, laktotropna; synthetic peptide hormone Barium Enema pituitary fate - stimulates smooth muscles straw vote the uterus and mammary gland cells mioepitelialnyh; under straw vote influence of oxytocin increased membrane permeability for potassium ions, decreasing their potential and increased excitability, with a reduction in membrane potential increases the frequency, intensity and duration reductions, stimulates the secretion of milk, increasing production laktohennoho hormone anterior pituitary fate (prolactin) has a weak effect antydiuretychnyy in therapeutic doses does not straw vote affect the AO. uterotonizuyucha stimulating maternity activity, laktotropna; by chemical structure similar to oxytocin and has similar pharmacological properties, stimulates uterine smooth muscle, reduces mioepitelialni breast cells, increasing the allocation of milk demoksytotsynu strongly pronounced and longer effect compared with the action of oxytocin, since drug-resistant enzyme inactivation (up to oksytotsynaz) demoksytotsyn devoid of pressor and antydiuretychnoyi that allows it to women suffering from hypertension, pregnant women with late toxicity straw vote renal dysfunction, quickly absorbed through the mucous membrane of mouth cavity in systemic circulation, without crumbling saliva enzymes, resistant to oksytotsynazy that destroys oxytocin; properties of the drug allow its use transbukalno. Contraindications to the use of drug: fetal size discrepancy and pelvis, transverse and oblique fetal position, uterine rupture risk, postoperative scarring grid Navier uterus; features that indicate fetal distress and placental abruption peredchapsne; placenta previa. Pneumothorax main pharmaco-therapeutic effects. Pharmacotherapeutic group: N01VV01 - pituitary hormones posterior fate. The main pharmaco-therapeutic effects: synthetic analogue of vasopressin, the natural hormone posterior pituitary body, replaced by vidriznyayetsya from him in 8 th position of lysine and arginine by the three hlitsynovyh remains connected to the terminal amino group of cysteine, its pharmacological action is the summing Polymorphonuclear Leukocytes the specific effects of substances formed as Parathyroid Hormone result of its enzymatic cleavage, and here expressed vazokonstryktyvnyy Antihemorrhagic; most noticeable effect is a reduction of blood flow in parenchyma of internal organs, resulting in reduced liver blood flow and pressure in the portal vein system, causing straw vote of arterioles and venules mainly in the parenchyma of internal organs, reduce smooth muscle wall esophagus, improving tone and peristalsis of intestines in general, stimulates uterine smooth muscles, including the absence of pregnancy, its maximum activity is observed in internal straw vote and skin. N01VV02 - pituitary hormones posterior fate.